Alexander Roesch retweeted
New content 🌟Perspective🌟
"Targeting therapy-persistent residual disease"
by Xiaoxiao Sun, Lani Wu, Steven Altschuler & Aaron Hata @ucsfpharmacy @MGHCancerCenter
🔗nature.com/articles/s43018-0…
Alexander Roesch retweeted
Revisit @jasonlukemd and @AdnanKhattakOnc's recent publication summarizing the latest top advances in #melanoma research: acsjournals.onlinelibrary.wi… @OncoAlert #ESMO24
As part of our partnership with @AmericanCancer 🇺🇸Journals, @OncoAlert 🚨Proudly presents CANCER Section Editor @jasonlukemd who presented
presents original research during the #melanoma mini oral session at #ESMO24
Revisit his article cowritten with @AdnanKhattakOnc
on the top advances in melanoma for 2023:
acsjournals.onlinelibrary.wi…
@JournalCancer @RamalingamMD @billdahutmd @UPMCHillmanCC @PittDeptofMed @CureMelanoma @MelanomaReAlli @AIMatMelanoma @MelanomaCanada @melanomasupport @saveyourskinfdn
#OncoAlertAF
@nataliagandur @acampsmalea @BiagioRicciutMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @lungoncdoc @bavilima @realbowtiedoc @Erman_Akkus @DrFMartinelli @Lucarecco @heinrich_kat
Alexander Roesch retweeted
🔬✨Join us for this exciting lecture hosted by CRU337 @dfg_public as part of the "Sex and Gender in the Life Sciences" series @unidue . Discover the analytical potential of sex differences in melanoma.🔗Join: uni-due.zoom-x.de/j/68548836…
#SexGenderUDE #sexandgendersensitive medicine
Congrats! Very important observation and conceptual (cancer overarching) framework.
⚠️⚠️⚠️Publication alert!⚠️⚠️⚠️
nature.com/articles/s41556-0…
Congratulations #BrabletzLab and @KoeberleLab for this amazing study.
Happy to have played a tiny role
#ferroptosis #lipidmetabolism #cancerplasticity
6
163
Alexander Roesch retweeted
Highlights from this year’s @crc1430 retreat in beautiful Zons! Big thanks to everyone for the exciting talks and fantastic poster sessions. #Science #Collaboration #CRC1430
Exciting scientific exchange at the annual @crc1430 retreat on the banks of river Rhine
Alexander Roesch retweeted
🎊Congratulations to Dr. Renata Varaljai @renivaraljai from the Roesch lab @LabRoesch for receiving the Top Young Science Best Paper Award 2024 from the UDE Medical Faculty! 🔬🏆Read the awarded paper here: nature.com/articles/s43018-0…
Alexander Roesch retweeted
Thank you so much for the invitation! I am looking forward to it.
@unidue_zmb @SEFAGIA_ @WAutophagy @MedEssen
Exciting visit @crc1430 @unidue! We have the pleasure of hosting Silvia Vega-Rubín-de-Celis @vega_rubin from the Institute of Cell Biology @UniklinikEssen
for a talk on the 'Targeting autophagic vulnerabilities for cancer treatment'. See you tomorrow on June 4th!
Alexander Roesch retweeted
Novelty needs time. For the first 3 years after publication, a highly novel paper is less likely to be cited than a relatively non-novel paper. But after 15 years, they are 60% more likely to be highly cited. Don't let the short-term view discourage risky research!
Alexander Roesch retweeted
Why does Elsevier @ElsevierConnect promote racial profiling by asking reviewers about race, gender etc. Scientific review should be independent of any such thing and solely focused on scientific content.
Alexander Roesch retweeted
This study adds to recent studies bringing IL2 back into the spotlight (nature.com/articles/s41586-0…) and further highlights precision targeting of immunostimulatory signals to specific immune cell populations as a promising therapeutic strategy 12/n
Alexander Roesch retweeted
Utilizing the patient-derived tumor fragment (PDTF) platform previously developed by the lab (nature.com/articles/s41591-0…, sciencedirect.com/science/ar…), we investigated whether and how CD8-IL2 can reinvigorate antitumor T cell immunity in human tumors 6/n
Alexander Roesch retweeted
Die sog. Verbesserung der Arbeitsbedingungen in der Wissenschaft bedeutet:4 Jahre nach dem Erwerb des Doktorgrades wird man entweder arbeitslos oder Professor:in.(Das klappt in dem Zeitraum fast nie.) Das Gesetz führt zu noch weniger personellen Diversität als bisher.#WissZeitVG
Das Bundeskabinett hat heute die Reform des #WissZeitVG beschlossen. Damit verbessern wir die Arbeitsbedingungen für #Wissenschaftlerinnen und #Wissenschaftler. 🎓
Alle Details sind hier nachzulesen: bmbf.de/wisszeitvg
Our latest work in @NatureCancer shows how immunotherapy responses of patients with metastatic melanoma are linked to interleukin-17 signaling. 1/ nature.com/articles/s43018-0…
In sum, our study revealed that melanomas with pre-existing IL-17 signaling at BL might respond better to dual ICI. IL-17 promotes a favorable tumor microenvironment with enhanced immune cell infiltration, including neutrophils, and boosting T cell activation. 18/
1
176
Our THANK YOU go to all of the co-authors, members of @LabRoesch, collaborators @thommen_ds, @cru337, @crc1430, the core facilities @UniklinikEssen, @unidue_zmb, and the funding agencies Brigitte und Dr. Konstanze Wegener-Stiftung, @Novartis, @dfg_public 19/end
1
187
























